Cumberland Pharmaceuticals Inc. (CPIX)
USD 4.19
(3.2%)
USD 4.19
(3.2%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 6.09 Million | 8.45 Million | 6.34 Million | 5.41 Million | 3.05 Million | 3.11 Million |
| Net Income | -6.27 Million | -5.65 Million | -3.6 Million | -3.41 Million | -3.54 Million | -7.03 Million |
| Depreciation & Amortization | 5.77 Million | 5.32 Million | 4.6 Million | 4.74 Million | 4.4 Million | 2.98 Million |
| Deferred income taxes | -4.44 Million | - | -192.81 Thousand | 21.8 Thousand | 65.4 Thousand | 81.88 Thousand |
| Stock-based compensation | 365.04 Thousand | 447.5 Thousand | 741.86 Thousand | 1.04 Million | 1.48 Million | 1.36 Million |
| Change in working capital | 4.63 Million | 10.97 Million | 8.18 Million | 3.53 Million | 1.58 Million | 5.87 Million |
| Other non-cash items | 6.04 Million | -2.64 Million | -3.39 Million | -515.71 Thousand | -936.53 Thousand | -150.44 Thousand |
| Investing Cash Flow | -105.69 Thousand | -13.67 Million | -501.89 Thousand | -1.75 Million | 2.29 Million | -27.72 Million |
| Investments in PPE | -453.05 Thousand | -2.07 Million | -354.46 Thousand | -2.11 Million | -1.01 Million | -4.27 Million |
| Acquisitions | - | -13.5 Million | - | - | -5 Million | -20 Million |
| Investment purchases | - | - | -200 Thousand | - | -11.74 Million | -19.57 Million |
| Sales/Maturities of investments | - | - | - | - | 20.06 Million | 16.12 Million |
| Other Investing Activities | 347.35 Thousand | 1.89 Million | 52.56 Thousand | 356.13 Thousand | 7.54 Million | -7.26 Million |
| Financing Cash Flow | -7.42 Million | -2.06 Million | -3.55 Million | -7.11 Million | -5.08 Million | 7.13 Million |
| Debt repayment | -3.41 Million | -51.7 Million | -59 Million | -62.5 Million | -77.5 Million | -45.8 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -740.53 Thousand | -1.05 Million | -1.38 Million | -1.85 Million | -3.49 Million | -2.87 Million |
| Common Stock Issuance | - | - | - | -135.4 Thousand | - | 200.9 Thousand |
| Other Financing Activities | -3.26 Million | 50.69 Million | 56.83 Million | 57.37 Million | 75.91 Million | 55.61 Million |
| Accounts receivables | 3.4 Million | -6.11 Million | 5.5 Million | -4.51 Million | -1.39 Million | 550.86 Thousand |
| Accounts payables | 3.72 Million | 15.06 Million | -757.59 Thousand | 6.56 Million | 3.22 Million | 4.3 Million |
| Inventory | -23.14 Thousand | 1.37 Million | 4.81 Million | 2.13 Million | 1.1 Million | 460.5 Thousand |
| Other working capital | -2.47 Million | 644.91 Thousand | -1.37 Million | -648.84 Thousand | -1.34 Million | 552.59 Thousand |
| Cash at beginning of period | 19.75 Million | 27.04 Million | 24.75 Million | 28.21 Million | 27.93 Million | 45.41 Million |
| Cash at end of period | 18.32 Million | 19.75 Million | 27.04 Million | 24.75 Million | 28.21 Million | 27.93 Million |
| Capital Expenditure | -453.05 Thousand | -2.07 Million | -354.46 Thousand | -2.11 Million | -1.01 Million | -4.27 Million |
| Effect of forex changes on cash | 1.43 Million | - | - | - | - | - |
| Net cash flow / Change in cash | -1.43 Million | -7.28 Million | 2.28 Million | -3.45 Million | 273.67 Thousand | -17.47 Million |
| Free Cash Flow | 5.64 Million | 6.37 Million | 5.98 Million | 3.3 Million | 2.03 Million | -1.16 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.08 Million | -1.94 Million | -6.29 Million | -6.27 Million | -1.06 Million | 862.15 Thousand |
| Depreciation & Amortization | 1.42 Million | 1.43 Million | 1.23 Million | 5.77 Million | 1.24 Million | 1.2 Million |
| Deferred income taxes | - | - | -5.27 Million | -4.44 Million | - | - |
| Stock-based compensation | 71.95 Thousand | 78.75 Thousand | 93.89 Thousand | 365.04 Thousand | 83.11 Thousand | 97.87 Thousand |
| Change in working capital | -1.07 Million | -1.39 Million | 2.18 Million | 4.63 Million | 1.74 Million | 1.49 Million |
| Other non-cash items | 3.72 Million | 4.17 Million | 9.08 Million | 6.04 Million | -771.64 Thousand | 1.57 Million |
| Investing Cash Flow | -46.8 Thousand | -58.18 Thousand | 260.63 Thousand | -105.69 Thousand | -95.07 Thousand | -96.8 Thousand |
| Investments in PPE | -46.8 Thousand | -58.18 Thousand | -86.71 Thousand | -453.05 Thousand | -95.07 Thousand | -96.8 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -39.62 Thousand | -16.56 Thousand | 347.35 Thousand | 347.35 Thousand | -41.93 Thousand | -24.61 Thousand |
| Financing Cash Flow | -309.57 Thousand | 2.42 Million | -1.48 Million | -7.42 Million | -882.59 Thousand | -3.27 Million |
| Debt repayment | -7448.00 | -3.3 Million | -138.98 Thousand | -3.41 Million | -8 Million | -10.92 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -134.24 Thousand | -247.6 Thousand | -188.97 Thousand | -740.53 Thousand | -201.65 Thousand | -162.79 Thousand |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -182.77 Thousand | -630.7 Thousand | -1.15 Million | -3.26 Million | 7.31 Million | 7.81 Million |
| Accounts receivables | -795.17 Thousand | -1.06 Million | 2.51 Million | 3.4 Million | -54.56 Thousand | 463.31 Thousand |
| Accounts payables | -1.28 Million | -645.54 Thousand | 1.82 Million | 3.72 Million | 1.36 Million | 1.63 Million |
| Inventory | 1.07 Million | 170.46 Thousand | -441.49 Thousand | -23.14 Thousand | 650.46 Thousand | 91.44 Thousand |
| Other working capital | -67.49 Thousand | 148.52 Thousand | -1.7 Million | -2.47 Million | -222.17 Thousand | -696.56 Thousand |
| Cash at beginning of period | 18.54 Million | 18.32 Million | 18.5 Million | 19.75 Million | 18.24 Million | 16.38 Million |
| Cash at end of period | 17.33 Million | 18.54 Million | 18.32 Million | 18.32 Million | 18.5 Million | 18.24 Million |
| Capital Expenditure | -46.8 Thousand | -58.18 Thousand | -86.71 Thousand | -453.05 Thousand | -95.07 Thousand | -96.8 Thousand |
| Effect of forex changes on cash | - | - | 186.34 Thousand | 1.43 Million | 1.05 Million | - |
| Net cash flow / Change in cash | -1.21 Million | 226.86 Thousand | -186.34 Thousand | -1.43 Million | 258.87 Thousand | 1.86 Million |
| Free Cash Flow | -902.46 Thousand | -2.19 Million | 953.4 Thousand | 5.64 Million | 1.14 Million | 5.13 Million |
PAVS
EKDHF
6255
ATMP3
007590
SLV